Skip to main content
. 2012 Aug 18;5(4):448–451. doi: 10.3980/j.issn.2222-3959.2012.04.08

Table 2. Percentage of corneal opacity scores of the control, bevacizumab (2.5mg) and ranibizumab (1mg) groups.

Groups Corneal opacity score (%)
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
Saline 0 0 20 40 40
Bevacizumab 0 60 40 0 0
Ranibizumab 0 40 40 20 0